Xeris Biopharma Holdings, Inc.

XERS

NASDAQ

Healthcare

Biotechnology

Chicago, IL, US394 employeesxerispharma.com

$6.03

-0.01(-0.25%)

Mkt Cap $1.0B

$3.95

$9.90

52-Week Range

At a Glance

AI-generated

Revenue breakdown: Gvoke (37%), Recorlev (35.4%), Keveyis (23.4%).

8-K

Xeris Biopharma Holdings, Inc. announced that its subsidiaries, Xeris Pharmaceuticals, Inc. and Strongbridge Dublin Limited, filed a patent infringement lawsuit under the Hatch-Waxman Act against Torrent Pharmaceuticals Limited (along with its affiliate) and Somerset Therapeutics, LLC (along with its affiliates) in the U.S. District Court for the District of New Jersey to block generic versions of RECORLEV® (levoketoconazole). The lawsuit covers four Orange Book-listed patents expiring in March 2040 and seeks an injunction until patent expiration.

$1.0B

Market Cap

$303M

Revenue

$575.6K

Net Income

Employees394

Fundamentals

How The Business Makes Money

Revenue by Segment

Gvoke37%($244M)

Recorlev35.4%($233M)

Keveyis23.4%($154M)

Royalty Contract And Other Revenue3.9%($26M)

Product Other0.3%($2M)

Activity

What Changed Recently

Financial Results

Mar 1, 2026

, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended

Financial Results

Jan 7, 2026

in this Current Report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exch

Regulation FD

Feb 26, 2026

by reference. The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of

Peer Companies

Company	Price	Change	Market Cap	P/E
VERAVera Therapeutics, Inc.	$40.82	+0.79%	$2.9B	-8.7
CLDXCelldex Therapeutics, Inc...	$31.00	-0.85%	$2.1B	-8.2
BCRXBioCryst Pharmaceuticals,...	$9.03	-3.78%	$1.9B	7.8
SIONSionna Therapeutics, Inc.	$40.58	-1.76%	$1.8B	-19.3
HRMYHarmony Biosciences Holdi...	$27.77	-0.68%	$1.6B	10.0
IMCRImmunocore Holdings plc	$30.88	+1.86%	$1.6B	-57.1
MAZEMaze Therapeutics, Inc.	$28.82	-0.77%	$1.4B	-17.8
ABCLAbCellera Biologics Inc.	$3.54	+0.71%	$1.1B	-6.9

Analyst View

Company Profile

CIK0001867096

ISINUS98422E1038

CUSIP98422E103

Phone844 445 5704

Address180 North LaSalle Street, Chicago, IL, 60601, US

SEC EDGAR